428 related articles for article (PubMed ID: 12037229)
1. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest.
Boni E; Corda L; Franchini D; Chiroli P; Damiani GP; Pini L; Grassi V; Tantucci C
Thorax; 2002 Jun; 57(6):528-32. PubMed ID: 12037229
[TBL] [Abstract][Full Text] [Related]
2. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients.
Tantucci C; Duguet A; Similowski T; Zelter M; Derenne JP; Milic-Emili J
Eur Respir J; 1998 Oct; 12(4):799-804. PubMed ID: 9817148
[TBL] [Abstract][Full Text] [Related]
3. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD.
Dellacà RL; Pompilio PP; Walker PP; Duffy N; Pedotti A; Calverley PM
Eur Respir J; 2009 Jun; 33(6):1329-37. PubMed ID: 19164347
[TBL] [Abstract][Full Text] [Related]
4. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
5. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between expiratory muscle dysfunction and dynamic hyperinflation in advanced chronic obstructive pulmonary disease].
Mota S; Güell R; Barreiro E; Casan P; Gea J; Sanchis J
Arch Bronconeumol; 2009 Oct; 45(10):487-95. PubMed ID: 19631439
[TBL] [Abstract][Full Text] [Related]
7. [Expiratory flow limitation detected by negative expiratory pressure in patients with chronic obstructive pulmonary disease].
Chen AH; Chen RC; Li JM; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):236-9. PubMed ID: 16750038
[TBL] [Abstract][Full Text] [Related]
8. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
Hadcroft J; Calverley PM
Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
[TBL] [Abstract][Full Text] [Related]
9. Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients.
Theodorakopoulou EP; Gennimata SA; Harikiopoulou M; Kaltsakas G; Palamidas A; Koutsoukou A; Roussos C; Kosmas EN; Bakakos P; Koulouris NG
Respir Physiol Neurobiol; 2017 Apr; 238():47-54. PubMed ID: 28109942
[TBL] [Abstract][Full Text] [Related]
10. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease.
Chen R; Chen R; Chen X; Chen L
Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934
[TBL] [Abstract][Full Text] [Related]
11. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
13. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
14. Flow limitation and dynamic hyperinflation during exercise in COPD patients after single lung transplantation.
Murciano D; Ferretti A; Boczkowski J; Sleiman C; Fournier M; Milic-Emili J
Chest; 2000 Nov; 118(5):1248-54. PubMed ID: 11083671
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114
[TBL] [Abstract][Full Text] [Related]
16. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD.
Man WD; Mustfa N; Nikoletou D; Kaul S; Hart N; Rafferty GF; Donaldson N; Polkey MI; Moxham J
Thorax; 2004 Jun; 59(6):471-6. PubMed ID: 15170026
[TBL] [Abstract][Full Text] [Related]
17. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
[TBL] [Abstract][Full Text] [Related]
18. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
[TBL] [Abstract][Full Text] [Related]
19. [Expiratory flow limitation detected by negative expiratory pressure in patients with bronchial asthma].
Zhang NF; Chen AH; Chen RC; Li JM; Liu Q; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):816-20. PubMed ID: 17327084
[TBL] [Abstract][Full Text] [Related]
20. Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis.
Goetghebeur D; Sarni D; Grossi Y; Leroyer C; Ghezzo H; Milic-Emiri J; Bellet M
Eur Respir J; 2002 Mar; 19(3):492-8. PubMed ID: 11936528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
